Interleukin-1 blockade in polygenic autoinflammatory disorders: where are we now?

H Malcova, T Milota, Z Strizova… - Frontiers in …, 2021 - frontiersin.org
Polygenic autoinflammatory diseases (AIDs), such as systemic juvenile idiopathic arthritis
(sJIA), adult-onset Still's disease, Kawasaki disease, idiopathic recurrent pericarditis (IRP) …

Update on the therapy of adult-onset Still's disease with a focus on IL-1-inhibition: a systematic review

C Kedor, S Tomaras, D Baeumer… - Therapeutic Advances …, 2021 - journals.sagepub.com
Introduction: The past decade has seen increasingly rapid advances in understanding the
pathogenic nature of adult-onset Still's disease (AOSD) and its shared symptoms with the …

Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations

P Ruscitti, P Di Benedetto, O Berardicurti, N Panzera… - Scientific reports, 2020 - nature.com
Ferritin is an iron-binding molecule, which comprises 24 subunits, heavy (FeH) and light
(FeL) subunits, suggested to have a pathogenic role by the 'hyperferritinemic syndrome'. In …

[HTML][HTML] New onset systemic lupus erythematosus after COVID-19 infection: a case report

L Ramachandran, VS Dontaraju, J Troyer… - AME Case …, 2022 - ncbi.nlm.nih.gov
COVID-19 is a respiratory viral illness that can have life threatening complications. While the
short-term sequela of COVID-19, including cytokine storm, is relatively well known, the long …

Off-label use of anti-IL-1 drugs in rheumatic diseases

S Stefania, R Colia, R Cinzia… - International …, 2021 - journals.sagepub.com
Interleukin-1 (IL-1) plays a key role in the pathogenesis of different rheumatic diseases.
There are now several agents available on the market capable of blocking IL-1. The proven …

“Neuroimmunoendocrinology” in Children with Rheumatic Diseases: How Glucocorticoids Are the Orchestra Director

MC Maggio, A Miniaci, R Gallizzi, A Civino - International Journal of …, 2023 - mdpi.com
The neural, the endocrine, and the immune systems are studied as distinct districts in
physiological and pathological settings. However, these systems must be investigated with …

Systemic juvenile idiopathic arthritis/pediatric still's disease, a syndrome but several clinical forms: Recent therapeutic approaches

P Quartier - Journal of Clinical Medicine, 2022 - mdpi.com
Background: Systemic Juvenile Idiopathic Arthritis (SJIA)/Pediatric Still's disease is
associated with different phenotypes and outcomes from currently available treatments …

Drug retention rates of biological agents in adult onset Still's disease

C Campochiaro, N Farina, A Tomelleri… - Seminars in Arthritis and …, 2021 - Elsevier
Objectives To assess drug retention rates (DRRs) and reasons for discontinuation of
biologic disease-modifying antirheumatic drugs (bDMARDs) in a large monocentric cohort of …

Current treatment options and safety considerations when treating adult-onset Still's disease

G Cavalli, N Farina, C Campochiaro… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Adult onset Still disease (AOSD) is a rare systemic inflammatory
condition. The clinical spectrum of this disease ranges from self-limiting forms with mild …

Performance of the modified systemic manifestation score for systemic juvenile idiopathic arthritis in adult-onset Still's disease

D Zhu, J Meng, J Jia, M Wang, Y Ma, H Shi, Y Sun… - Clinical …, 2023 - Springer
Objectives To compare the ability of the modified Systemic Manifestation Score (mSMS) and
the mPouchot score to distinguish adult-onset Still's disease (AOSD) with high disease …